Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-25-001344
Filing Date
2025-05-15
Accepted
2025-05-15 17:05:34
Documents
55
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q tdac-20250331x10q.htm   iXBRL 10-Q 692757
2 EX-31.1 tdac-20250331xex31d1.htm EX-31.1 11868
3 EX-31.2 tdac-20250331xex31d2.htm EX-31.2 11842
4 EX-32.1 tdac-20250331xex32d1.htm EX-32.1 5338
5 EX-32.2 tdac-20250331xex32d2.htm EX-32.2 5347
  Complete submission text file 0001410578-25-001344.txt   4081643

Data Files

Seq Description Document Type Size
6 EX-101.SCH tdac-20250331.xsd EX-101.SCH 43756
7 EX-101.CAL tdac-20250331_cal.xml EX-101.CAL 15425
8 EX-101.DEF tdac-20250331_def.xml EX-101.DEF 173148
9 EX-101.LAB tdac-20250331_lab.xml EX-101.LAB 302067
10 EX-101.PRE tdac-20250331_pre.xml EX-101.PRE 249625
58 EXTRACTED XBRL INSTANCE DOCUMENT tdac-20250331x10q_htm.xml XML 529450
Mailing Address 52 E 83RD ST. NEW YORK NY 10028
Business Address 52 E 83RD ST. NEW YORK NY 10028 (413) 204-2769
Translational Development Acquisition Corp. (Filer) CIK: 0001926599 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-42451 | Film No.: 25955208
SIC: 6770 Blank Checks
(CF Office: 05 Real Estate & Construction)